Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options A Literature Review /
Chronic pain conditions have a high socio-economic impact and represent a burden for patients, and their management is a challenge for healthcare professionals. Chronic migraine is one of the chronic primary headache disorders, which belong to chronic primary pain syndromes as per the new concept of...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2023
|
| Sorozat: | LIFE-BASEL
13 No. 3 |
| Tárgyszavak: | |
| doi: | 10.3390/life13030665 |
| mtmt: | 33723037 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/26876 |
| LEADER | 02306nab a2200253 i 4500 | ||
|---|---|---|---|
| 001 | publ26876 | ||
| 005 | 20230331080814.0 | ||
| 008 | 230331s2023 hu o 0|| Angol d | ||
| 022 | |a 2075-1729 | ||
| 024 | 7 | |a 10.3390/life13030665 |2 doi | |
| 024 | 7 | |a 33723037 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a Angol | ||
| 100 | 1 | |a Szok Délia | |
| 245 | 1 | 0 | |a Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options |h [elektronikus dokumentum] : |b A Literature Review / |c Szok Délia |
| 260 | |c 2023 | ||
| 300 | |a 26 | ||
| 490 | 0 | |a LIFE-BASEL |v 13 No. 3 | |
| 520 | 3 | |a Chronic pain conditions have a high socio-economic impact and represent a burden for patients, and their management is a challenge for healthcare professionals. Chronic migraine is one of the chronic primary headache disorders, which belong to chronic primary pain syndromes as per the new concept of multiple parenting. The aims of this review were to provide an overview of the latest classification systems involving both entities, the epidemiological data, and the currently recommended prophylactic treatment options for chronic migraine. Randomized controlled clinical trials, meta-analyses, real-world data, and review articles were analyzed. Chronic migraine is a prevalent and highly burdensome disease and is associated with high headache-related disability and worsening health-related quality of life. Treatment of chronic migraine includes pharmacological or, in drug-refractory cases, non-pharmacological (e.g., neuromodulatory) approaches. Among pharmacological treatment options, injectable botulinum toxin type A and calcitonin gene-related peptide-targeting human and fully humanized monoclonal antibodies (i.e., eptinezumab, erenumab, fremanezumab, and galcanezumab) are highly recommended in the preventive treatment of chronic migraine. Novel migraine-specific therapies offer a solution for this devastating and difficult-to-treat chronic pain condition. | |
| 650 | 4 | |a Klinikai orvostan | |
| 700 | 0 | 1 | |a Csáti Anett |e aut |
| 700 | 0 | 1 | |a Vécsei László |e aut |
| 700 | 0 | 1 | |a Tajti János |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/26876/1/SzokD.Chronicmigraineasaprimarychronicpainsyndromeandrecommendedprophylactictherapeuticoptions.pdf |z Dokumentum-elérés |